Cargando…

Human Antibody Repertoire following Ebola Virus Infection and Vaccination

Limited knowledge exists on the quality of polyclonal antibody response generated following Ebola virus (EBOV) infection compared with vaccination. Polyclonal antibody repertoire in plasma following EBOV infection in survivors was compared with ChAd3-MVA prime-boost human vaccination. Higher antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuentes, Sandra, Ravichandran, Supriya, Coyle, Elizabeth M., Klenow, Laura, Khurana, Surender
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058406/ https://www.ncbi.nlm.nih.gov/pubmed/32145646 http://dx.doi.org/10.1016/j.isci.2020.100920

Ejemplares similares

Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies
por: Ravichandran, Supriya, et al.
Publicado: (2022)

Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins
por: Fuentes, Sandra, et al.
Publicado: (2016)

Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome
por: Ravichandran, Supriya, et al.
Publicado: (2019)

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain
por: Lee, Jeehyun, et al.
Publicado: (2021)

Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
por: Ravichandran, Supriya, et al.
Publicado: (2020)

Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients
por: Tang, Juanjie, et al.
Publicado: (2021)

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model
por: Fuentes, Sandra, et al.
Publicado: (2017)

Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains
por: Lee, Jeehyun, et al.
Publicado: (2018)

Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins
por: Khurana, Surender, et al.
Publicado: (2020)

Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution
por: Ravichandran, Supriya, et al.
Publicado: (2021)

Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors
por: Meyer, Michelle, et al.
Publicado: (2018)

Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle
por: Dye, John M., et al.
Publicado: (2016)

Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex
por: Tang, Juanjie, et al.
Publicado: (2021)

Facile Discovery of a Diverse Panel of Anti-Ebola Virus Antibodies by Immune Repertoire Mining
por: Wang, Bo, et al.
Publicado: (2015)

Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
por: Khurana, Surender, et al.
Publicado: (2019)

Corrigendum: Facile Discovery of a Diverse Panel of Anti-Ebola Virus Antibodies by Immune Repertoire Mining
por: Wang, Bo, et al.
Publicado: (2016)

Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid
por: Lambe, Teresa, et al.
Publicado: (2016)

Comparison of SARS-CoV-2 Hyperimmune Immunoglobulins Following Infection Plus Vaccination vs Infection
por: Bellusci, Lorenza, et al.
Publicado: (2023)

Heterologous Prime-Boost Vaccination with MF59-Adjuvanted H5 Vaccines Promotes Antibody Affinity Maturation towards the Hemagglutinin HA1 Domain and Broad H5N1 Cross-Clade Neutralization
por: Khurana, Surender, et al.
Publicado: (2014)

Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2–infected individuals reveal unlinked immune signatures
por: Ravichandran, Supriya, et al.
Publicado: (2021)

Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization
por: Khurana, Surender, et al.
Publicado: (2015)

Windows of opportunity for Ebola virus infection treatment and vaccination
por: Nguyen, Van Kinh, et al.
Publicado: (2017)

Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors
por: Kreil, Thomas R.
Publicado: (2015)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

AID Activity in B Cells Strongly Correlates with Polyclonal Antibody Affinity Maturation in-vivo Following Pandemic 2009-H1N1 Vaccination in Humans
por: Khurana, Surender, et al.
Publicado: (2012)

Virus-Vectored Ebola Vaccines
por: Dolzhikova, I.V., et al.
Publicado: (2017)

Ebola and Marburg virus vaccines
por: Reynolds, Pierce, et al.
Publicado: (2017)

Recombinant Antibodies to the Ebola Virus Glycoprotein
por: Panina, A. A., et al.
Publicado: (2017)

Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective
por: Khurana, Surender
Publicado: (2018)

Approaches to Interrogating the Human Memory B-Cell and Memory-Derived Antibody Repertoire Following Dengue Virus Infection
por: Lyski, Zoe L., et al.
Publicado: (2019)

Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences
por: Galson, Jacob D., et al.
Publicado: (2015)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

Ebola Virus Antibody Prevalence in Dogs and Human Risk
por: Allela, Loïs, et al.
Publicado: (2005)

Variations in antibody repertoires correlate with vaccine responses
por: Safonova, Yana, et al.
Publicado: (2022)

Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
por: Qiu, Xiangguo, et al.
Publicado: (2012)

Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys
por: Oswald, Wendelien B, et al.
Publicado: (2007)

Ebola Virus Antibodies in Fruit Bats, Bangladesh
por: Olival, Kevin J., et al.
Publicado: (2013)

Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors
por: Fan, Pengfei, et al.
Publicado: (2020)

Antibody repertoire sequencing analysis: Antibody repertoire sequencing analysis
por: Zhang, Senxin, et al.
Publicado: (2022)

Understanding the human antibody repertoire
por: Rees, Anthony R
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8dnd86og0g876dqb425h6umm1r